HK Stock Market Move | JACOBSON PHARMA (02633) drops nearly 7%, mid-year earnings decrease by 5.36% year-on-year, dividend payout increases by 20% year-on-year.

JACOBSON PHARMA (02633) fell by nearly 7%, closing at a 6.76% drop to HK$1.38, with a turnover of HK$33.435 million. In terms of news, JACOBSON PHARMA released its interim results for the six months ending September 30, 2025. The group achieved revenue of HK$767 million during the period, a decrease of 5.36% year-on-year; profit attributable to equity holders of the company amounted to HK$142 million, an increase of 1.24% year-on-year; and basic earnings per share were 7.12 HK cents. The interim dividend per share was 4.25 HK cents, representing an increase of approximately 21.4% compared to the same period in 2024. The announcement also stated that during the reporting period, the group's revenue slightly decreased compared to the first half of the 2025 fiscal year, mainly due to the early end of the flu season, which led to a decrease in hospital admissions and clinic visits, resulting in a slowdown in demand for related medical services and medicines.